Suppr超能文献

相似文献

1
The role of FAK in tumor metabolism and therapy.
Pharmacol Ther. 2014 May;142(2):154-63. doi: 10.1016/j.pharmthera.2013.12.003. Epub 2013 Dec 9.
2
Focal adhesion kinase as a cancer therapy target.
Anticancer Agents Med Chem. 2010 Dec;10(10):735-41. doi: 10.2174/187152010794728648.
4
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
J Exp Clin Cancer Res. 2019 Jun 11;38(1):250. doi: 10.1186/s13046-019-1265-1.
5
Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
Chem Biol Drug Des. 2021 Mar;97(3):774-794. doi: 10.1111/cbdd.13808. Epub 2020 Nov 27.
6
Targeting FAK in anticancer combination therapies.
Nat Rev Cancer. 2021 May;21(5):313-324. doi: 10.1038/s41568-021-00340-6. Epub 2021 Mar 17.
7
Focal adhesion kinase: a potential target in cancer therapy.
Biochem Pharmacol. 2007 Mar 1;73(5):597-609. doi: 10.1016/j.bcp.2006.08.011. Epub 2006 Sep 25.
9
Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
Anticancer Agents Med Chem. 2011 Sep;11(7):593-9. doi: 10.2174/187152011796817727.
10
Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Expert Opin Ther Pat. 2014 Oct;24(10):1077-100. doi: 10.1517/13543776.2014.948845. Epub 2014 Aug 12.

引用本文的文献

3
Exploiting Matrix Stiffness to Overcome Drug Resistance.
ACS Biomater Sci Eng. 2024 Aug 12;10(8):4682-4700. doi: 10.1021/acsbiomaterials.4c00445. Epub 2024 Jul 5.
4
The state of the art in secondary pharmacology and its impact on the safety of new medicines.
Nat Rev Drug Discov. 2024 Jul;23(7):525-545. doi: 10.1038/s41573-024-00942-3. Epub 2024 May 21.
5
[Protective effect of FAK inhibitor PF-562271 against human umbilical vein endothelial cell injury induced by aging platelets].
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Feb 20;44(2):252-259. doi: 10.12122/j.issn.1673-4254.2024.02.07.
7
Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses.
Front Mol Biosci. 2022 Dec 1;9:984564. doi: 10.3389/fmolb.2022.984564. eCollection 2022.
8
Functional and clinical characteristics of focal adhesion kinases in cancer progression.
Front Cell Dev Biol. 2022 Nov 2;10:1040311. doi: 10.3389/fcell.2022.1040311. eCollection 2022.
10
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK.
Nat Commun. 2022 Oct 8;13(1):5945. doi: 10.1038/s41467-022-33493-5.

本文引用的文献

1
Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.
PLoS One. 2013 Aug 2;8(8):e70804. doi: 10.1371/journal.pone.0070804. Print 2013.
2
MYC, metabolism, cell growth, and tumorigenesis.
Cold Spring Harb Perspect Med. 2013 Aug 1;3(8):a014217. doi: 10.1101/cshperspect.a014217.
3
Targeting SREBP-1-driven lipid metabolism to treat cancer.
Curr Pharm Des. 2014;20(15):2619-26. doi: 10.2174/13816128113199990486.
4
Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity.
Bioorg Med Chem Lett. 2013 Aug 15;23(16):4552-6. doi: 10.1016/j.bmcl.2013.06.038. Epub 2013 Jun 24.
5
Current understanding of the molecular biology of pancreatic neuroendocrine tumors.
J Natl Cancer Inst. 2013 Jul 17;105(14):1005-17. doi: 10.1093/jnci/djt135. Epub 2013 Jul 9.
7
Sirt4: the glutamine gatekeeper.
Cancer Cell. 2013 Apr 15;23(4):427-8. doi: 10.1016/j.ccr.2013.04.003.
9
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
Nature. 2013 Apr 4;496(7443):101-5. doi: 10.1038/nature12040. Epub 2013 Mar 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验